Sitafloxacin — CAS 127254-12-0

Sitafloxacin is a potent fourth-generation fluoroquinolone antibiotic with exceptionally broad-spectrum antibacterial activity, including activity against drug-resistant organisms such as MRSA and PRSP. It inhibits DNA gyrase and topoisomerase IV. Mediocon Inc manufactures GMP-certified Sitafloxacin API at its Aurangabad facility.

• Respiratory tract infections
• Urinary tract infections
• Broad-spectrum antibiotic therapy
• Drug-resistant bacterial infections

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / EP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support